LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy
Clinical trial NCT01380730 · COMPLETED
Trial details
- NCT number
- NCT01380730
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-04-05
- Enrollment
- 631
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.